3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Terminated
2
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Myeloid
2
Lymphoid
2
Conditions
Leukemia
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms
3
Lymphoma, Non-Hodgkin
3
Hematologic Neoplasms
3
Sarcoma
2
Osteosarcoma
2
Neoplasm Metastasis
2
Myeloproliferative Disorders
2
Medulloblastoma
2
Lymphoma
2
Kidney Neoplasms
2
Hodgkin Disease
2
Carcinoma, Renal Cell
2
Burkitt Lymphoma
2
Wilms Tumor
1
Thalassemia
1
Stomach Neoplasms
1
Rhabdoid Tumor
1
Retinoblastoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Optic Nerve Glioma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Myelodysplastic Syndromes
1
Myasthenia Gravis
1
Lymphoma, Follicular
1
Liver Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Interventions
Cyclophosphamide
14
fludarabine phosphate
13
ruxolitinib
9
Busulfan
9
Antilymphocyte Serum
9
fludarabine
8
Peripheral Blood Stem Cell Transplantation
8
Filgrastim
8
Whole-Body Irradiation
7
Cyclosporine
7
Tacrolimus
6
Radiotherapy
6
Mycophenolic Acid
6
Methylprednisolone
6
Methotrexate
5
Melphalan
5
Cytarabine
5
Cord Blood Stem Cell Transplantation
5
Azacitidine
5
Imatinib Mesylate
4
Alemtuzumab
4
ponatinib
3
parsaclisib
3
fedratinib
3
Stem Cell Transplantation
3
Rituximab
3
Granulocyte Colony-Stimulating Factor
3
Etoposide
3
Decitabine
3
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Myeloproliferative Disorders
×
Mesna
×
Clear all
NCT00578461
2016-04-22
REGKINE
Baylor College of Medicine
Phase NA
Terminated
26 enrolled
7 charts
NCT00578539
2016-04-22
REGALE
Baylor College of Medicine
Phase NA
Terminated
24 enrolled
7 charts